PLoS ONE (Jan 2021)

Effect of community antiretroviral therapy on treatment outcomes among stable antiretroviral therapy patients in Nigeria: A quasi experimental study.

  • Patrick Dakum,
  • Juliet Ajav-Nyior,
  • Timothy A Attah,
  • Gbenga A Kayode,
  • Asabe Gomwalk,
  • Helen Omuh,
  • Halima Ibrahim,
  • Mercy Omozuafoh,
  • Abimiku Alash'le,
  • Charles Mensah,
  • Young Oluokun,
  • Franca Akolawole

DOI
https://doi.org/10.1371/journal.pone.0250345
Journal volume & issue
Vol. 16, no. 4
p. e0250345

Abstract

Read online

ObjectivesThis study evaluates the effect of Community Anti-retroviral Groups on Immunologic, Virologic and clinical outcomes of stable Antiretroviral Therapy patients in Nigeria.MethodA cohort of 251 eligible adults (≥18 years) on first-line ART for at least 6 months with CD4 counts >200 cells/mm3 and viral load ResultOut of the 251 stable antiretroviral therapy adults enrolled, 186 (75.3%) were female, 52 (22.7%) had attained post-secondary education and the mean age of participants was 38 years (SD: 9.5). Also, 66 (27.9%) were employed while 125 (52.7%) were self-employed and 46(19.41%) unemployed. 246 (98.0%) of the participants were retained in care. While there was no statistically significant change in the CD4 counts (456cells/mm3 vs 481cells/mm3 P-0.489) and Log10 viral load (3.54c/ml vs 3.69c/ml P-0.359) after one year of devolvement into the community, we observed a significant increase in body weight (60.8 vs 65, P-0.01).ConclusionThis study demonstrates that community antiretroviral therapy has a potential of maintaining optimum treatment outcomes while improving adherence and retention, and reducing the burden of HIV treatment on the health facility. This study provides baseline information for further research and vital information for HIV program implementers planning to decentralize the management of stable antiretroviral therapy clients.